Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
MLR-1023
DRUG
2 trials
Sponsors
Melior Pharmaceuticals
Conditions
Type 2 Diabetes
Type 2 Diabetes Mellitus
Phase 2
Adult Subjects With Uncontrolled Type 2 Diabetes
Completed
NCT02317796
Melior Pharmaceuticals
Type 2 Diabetes
Start: 2014-12-31
End: 2016-02-29
Updated: 2016-09-26
An Add-on Study of MLR-1023 in Adults With Uncontrolled Type 2 Diabetes on Metformin Therapy
NCT03279263
Melior Pharmaceuticals
Type 2 Diabetes Mellitus
Start: 2017-09-01
End: 2019-09-30
Target: 400
Updated: 2019-01-09
Related Papers
MLR-1023 Treatment in Mice and Humans Induces a Thermogenic Program, and Menthol Potentiates the Effect
Pharmaceuticals
2021-11-22
5 citations
A novel non-PPARgamma insulin sensitizer: MLR-1023 clinicalproof-of-concept in type 2 diabetes mellitus.
2020-02-02
10 citations